Archives of Gynecology and Obstetrics

, Volume 246, Supplement 1, pp S45–S52 | Cite as

The advantages of a gonadotropin releasing hormone agonist (leuprolide acetate) in conjunction with gonadotropins for controlled ovarian hyperstimulation in IVF and GIFT cycles

  • J. F. Kerin
Zweites Hauptthema/Deuxième Thême Principal Evolution des Méthodes Diagnostiques et Thérapeutiques des Troubles de L'ovulation


Public Health Acetate Leuprolide Control Ovarian Hyperstimulation Leuprolide Acetate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Knobil E (1980) The neuroendocrine control of the menstrual cycle. Recent Prog Horm Res 36:53–88Google Scholar
  2. 2.
    Meldrum DR, Tsao Z, Monroe SE (1984) Stimulation of LH fragments with reduced bioactivity following GnRH agonist administration in women. J Clin Endocrinol Metab 58:755–757Google Scholar
  3. 3.
    Serafini P, Stone B, Kerin J, Batzofin J, Quinn P, Marrs R (1988) An alternate approach to controlled ovarian hyperstimulation in “poor responders”: pretreatment with a gonadotropin-releasing hormone analog. Fertil Steril 49:90–95Google Scholar
  4. 4.
    Brzyski RG, Mausher SJ, Droesch K, Simonetti S, Jones GS, Rosenwaks Z (1988) Follicular atresia associated with concurrent initiation of gonadotropin-releasing hormone agonist and follicle-stimulating hormone for oocyte recruitment. Fertil Steril 50:917–921Google Scholar
  5. 5.
    Katayama KP, Roesler M, Gunnarson C, Stehlik E, Jagusch S (1988) Short-term use of gonadotropin-releasing hormone agonist (Leuprolide) for in vitro fertilization. J In Vitro Fertil Embryo Transfer 5:332–334Google Scholar
  6. 6.
    Serafini P, Batzofin, J, Kerin J, Marrs R (1988) Pregnancy: a risk to initiation of leuprolide acetate during the luteal phase before controlled ovarian hyperstimulation. Fertil Steril 50:371–372Google Scholar

Copyright information

© Springer-Verlag 1989

Authors and Affiliations

  • J. F. Kerin
    • 1
  1. 1.Centre for Reproductive Medicine, Cedars-Sinai Medical CenterUCLA School of MedicineLos AngelesUSA

Personalised recommendations